INVIVO SENSITIVITY OF HEMATOPOIETIC PRECURSOR CELLS TO RECOMBINANT INTERFERON-ALPHA (RIFN-ALPHA), RECOMBINANT INTERFERON-GAMMA (RIFN-GAMMA) AND RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA (RTNF-ALPHA) IN NORMAL CONTROLS AND IN PATIENTS WITH CML - RELATIONSHIP TO THE INVIVO RESPONSE

被引：0
|
作者：
GEISSLER, D
GASTL, G
AULITZKY, W
TILG, H
KONWALINKA, G
HUBER, C
机构：
[1] UNIV HOSP INNSBRUCK,DEPT INTERNAL MED,A-6020 INNSBRUCK,AUSTRIA
[2] UNIV HOSP INNSBRUCK,DIV CLIN IMMUNOBIOL,A-6020 INNSBRUCK,AUSTRIA
来源：
JOURNAL OF INTERFERON RESEARCH | 1987年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：739 / 739
页数：1
相关论文
共 50 条
  • [11] ACUTE HEMATOLOGIC EFFECTS OF INTERFERON-ALPHA, INTERFERON-GAMMA, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-2
    AULITZKY, WE
    TILG, H
    VOGEL, W
    AULITZKY, W
    BERGER, M
    GASTL, G
    HEROLD, M
    HUBER, C
    ANNALS OF HEMATOLOGY, 1991, 62 (01) : 25 - 31
  • [12] INVITRO INTERACTION OF ALPHA-DIFLUOROMETHYL-ORNITHINE (DFMO) AND HUMAN RECOMBINANT INTERFERON-GAMMA (RIFN-GAMMA) ON HUMAN CANCER CELL-LINES
    SCHERDIN, G
    GARBRECHT, M
    KLOUCHE, M
    HOSSFELD, DK
    HOLZEL, F
    IMMUNOBIOLOGY, 1987, 175 (1-2) : 72 - 72
  • [13] Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-alpha (rIFN alpha 2a) and neutralizing-rIFN alpha 2a antibodies negative
    Russo, D
    Candoni, A
    Grattoni, R
    Minisini, R
    Rosti, G
    HAEMATOLOGICA, 1997, 82 (03) : 348 - 350
  • [14] PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA BY NORMAL AND MALIGNANT LYMPHOCYTES-B IN RESPONSE TO INTERFERON-ALPHA, INTERFERON-GAMMA AND INTERLEUKIN-4
    JANSEN, JH
    WIENTJENS, GJHM
    WILLEMZE, R
    KLUINNELEMANS, JC
    LEUKEMIA, 1992, 6 (02) : 116 - 119
  • [15] PHASE-I STUDY OF A COMBINATION OF RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    KURZROCK, R
    ROSENBLUM, MG
    QUESADA, JR
    SHERWIN, SA
    ITRI, LM
    GUTTERMAN, JU
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1677 - 1683
  • [16] GROWTH-INHIBITION OF HUMAN ENDOTHELIAL-CELLS BY HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA
    MAUERHOFF, T
    BELFIORE, A
    PUJOLBORRELL, R
    BOTTAZZO, GF
    TUMORI, 1994, 80 (04) : 301 - 305
  • [17] EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    DEMULDER, PHM
    OOSTERHOF, GON
    BOUFFIOUX, C
    VANOOSTEROM, AT
    VERMEYLEN, K
    SYLVESTER, R
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 371 - 375
  • [18] ENHANCEMENT OF CYTO-TOXICITY OF CISPLATIN INVITRO BY RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR AND OR RECOMBINANT HUMAN INTERFERON-ALPHA, INTERFERON-BETA AND INTERFERON-GAMMA
    KIM, CM
    HONG, WS
    LEE, JO
    KANG, TW
    KIM, YW
    SONG, JK
    YUN, TK
    KIM, CY
    JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (09): : 904 - 909
  • [19] RECOMBINANT INTERFERON-ALPHA, INTERFERON-BETA, AND INTERFERON-GAMMA ENHANCE THE PROLIFERATIVE RESPONSE OF HUMAN B-CELLS
    MORIKAWA, K
    KUBAGAWA, H
    SUZUKI, T
    COOPER, MD
    JOURNAL OF IMMUNOLOGY, 1987, 139 (03): : 761 - 766
  • [20] DIFFERENTIAL INVITRO EFFECTS OF ALPHA-RECOMBINANT INTERFERON (RIFN-ALPHA-A) AND GAMMA-RECOMBINANT INTERFERON (RIFN-GAMMA) ON THE EXPRESSION OF MELANOMA-ASSOCIATED ANTIGENS (MAA) P97 AND 240 KD ON MELANOMA CELL-LINE TS294
    MURRAY, JL
    PILLOW, JK
    ROSENBLUM, MG
    GUTTERMAN, JU
    HERSH, EM
    CARLO, DJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 313 - 313
12345